|
ZSCAN12P1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.27379999998101E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.57859999996946E-06 |
| Normal-vs-Stage2 |
6.085700E-02 |
| Normal-vs-Stage3 |
1.316060E-03 |
| Normal-vs-Stage4 |
5.075900E-03 |
| Stage1-vs-Stage2 |
6.286600E-01 |
| Stage1-vs-Stage3 |
8.901000E-01 |
| Stage1-vs-Stage4 |
7.401400E-01 |
| Stage2-vs-Stage3 |
7.405400E-01 |
| Stage2-vs-Stage4 |
8.595400E-01 |
| Stage3-vs-Stage4 |
8.895200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.69690048071425E-10 |
| Normal-vs-AfricanAmerican |
2.514500E-02 |
| Normal-vs-Asian |
8.301600E-01 |
| Caucasian-vs-AfricanAmerican |
3.267800E-01 |
| Caucasian-vs-Asian |
2.689600E-01 |
| AfricanAmerican-vs-Asian |
3.236200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.07759999601731E-08 |
| Normal-vs-Female |
3.475700E-03 |
| Male-vs-Female |
6.351900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.3766999995557E-07 |
| Normal-vs-Extreme_Weight |
1.33390000156552E-08 |
| Normal-vs-Obese |
4.04249999996775E-06 |
| Normal-vs-Extreme_Obese |
8.968000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.986200E-01 |
| Normal_Weight-vs-Obese |
9.261800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.337600E-01 |
| Extreme_Weight-vs-Obese |
5.200800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.027200E-01 |
| Obese-vs-Extreme_Obese |
4.399400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.367600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.6977999834088E-09 |
| Normal-vs-Age(61-80Yrs) |
1.94333999999907E-05 |
| Normal-vs-Age(81-100Yrs) |
4.19010048879898E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.421600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.732600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.165600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.865600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.896720E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.120180E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.66866520601161E-12 |
| Normal-VS-Type2 PRCC |
7.19580000030362E-07 |
| Normal-VS-KIRP CIMP |
4.636700E-03 |
| Normal-VS-Unclassified PRCC |
4.41400005435355E-09 |
| Type1 PRCC-VS-Type2 PRCC |
2.480600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.691370E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.056200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.802400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.581170E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.393600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.44719952372463E-10 |
| Normal-vs-N1 |
4.511700E-02 |
| Normal-vs-N2 |
6.669600E-02 |
| N0-vs-N1 |
8.242100E-02 |
| N0-vs-N2 |
1.046030E-02 |
| N1-vs-N2 |
8.717200E-01 |
|
|
